Lexacin

Levofloxacin, the active ingredient in Lexacin, is a fluoroquinolone presented as an ophthalmic solution for ocular use. It is indicated for the treatment of bacterial infections of the eye, including conjunctivitis and keratitis, in adult patients.

GNH USA supplies Lexacin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory‑approved batches for global distribution throughout.

Lexacin (levofloxacin) is used to treat bacterial infections of the eye by targeting common ocular pathogens.

- Bacterial conjunctivitis: eliminates causative bacteria, relieving redness, discharge, and irritation. - Bacterial keratitis: eradicates infiltrating organisms, promoting corneal healing and preserving vision. - Other ocular bacterial infections: controls infection in conditions such as blepharitis or postoperative endophthalmitis, reducing microbial load.

Levofloxacin ophthalmic solution may cause local and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Eye irritation: transient burning or stinging upon instillation. - Redness: mild conjunctival hyperemia. - Foreign body sensation: feeling of grit in the eye. - Blurred vision: temporary visual disturbance after dosing.

Serious or Rare Side Effects: - Tendon rupture: rare systemic tendon injury, especially in patients with risk factors. - Severe allergic reaction: anaphylaxis or angioedema requiring immediate medical attention. - Corneal ulceration: worsening of corneal integrity in susceptible individuals.

Before prescribing Lexacin, clinicians should consider the following precautions to ensure safe use.

- Patient history: assess for hypersensitivity to fluoroquinolones or other antibiotics. - Systemic exposure: avoid use in patients with a history of tendon disorders or recent corticosteroid therapy. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk, as safety data are limited. - Contact lens wearers: advise removal of lenses before instillation and delay reinsertion to reduce drug interaction. - Concomitant ocular medications: separate administration times by at least 5 minutes to avoid dilution. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Levofloxacin ophthalmic solution can interact with certain systemic and ocular agents; awareness of these interactions helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use may increase risk of tendon toxicity. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): combined use can heighten risk of corneal adverse events.

Moderate Interactions (Monitor Closely): - Corticosteroid eye drops: may mask signs of infection, requiring close monitoring. - Anticholinergic agents: can reduce tear production, potentially affecting drug distribution. - Herbal supplements containing quinine: may potentiate fluoroquinolone effects.